Prudential Financial’s ALX Oncology ALXO Stock Holding History

Prudential Financial’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.9K	Buy	+16,385	New	+$29.3K	﹤0.01%	2457
2023 Q2	–	Sell	-22,780	Closed	-$103K	–	2617
2023 Q1	$103K	Buy	22,780 +4,000	+21%	+$30.3K	﹤0.01%	2451
2022 Q4	$212K	Sell	18,780 -13,800	-42%	-$155K	﹤0.01%	2384
2022 Q3	$312K	Sell	32,580 -5,510	-14%	-$64.2K	﹤0.01%	2285
2022 Q2	$308K	Buy	+38,090	New	+$415K	﹤0.01%	2332
2021 Q4	–	Sell	-9,845	Closed	-$727K	–	2631
2021 Q3	$727K	Hold	9,845	–	–	﹤0.01%	1973
2021 Q2	$538K	Sell	9,845 -7,380	-43%	-$442K	﹤0.01%	2106
2021 Q1	$1.27M	Buy	17,225 +6,720	+64%	+$529K	﹤0.01%	1702
2020 Q4	$905K	Buy	10,505 +335	+3%	+$20.2K	﹤0.01%	1798
2020 Q3	$384K	Buy	+10,170	New	+$400K	﹤0.01%	2061

Other funds holding ALXO

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Prudential Financial's ALXO Position: Q2 2026 in Review

Prudential Financial opened a new position in ALX Oncology (ALXO) in Q2 2026: 16,385 shares worth $33.9K. The stake represents ﹤0.01% of the portfolio and ranks #2457 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ALXO as recently as Q1 2023.

Prudential Financial first reported a position in ALXO in Q3 2020 and has held it in 10 quarters since. The position peaked at $1.27M in Q1 2021. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

Prudential Financial held 16,385 shares of ALX Oncology worth $33.9K as of Q2 2026.
ALX Oncology was a new Prudential Financial position in Q2 2026.
ALX Oncology made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2457 holding.
Prudential Financial first reported a position in ALX Oncology in Q3 2020 and has held it in 10 quarters since.
Prudential Financial's ALX Oncology position peaked at $1.27M in Q1 2021.
94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.